Receives an exclusive license from Harvard University to integrate pioneering bioreactor technology that accommodates model ventricles and optional valves into the "human heart-in-a-jar" model
Leveraging extensive sales and marketing experience, as well as a multitude of long-standing connections and relationships in the pharmaceutical industry and biotechnology sector